AT

Avalo Therapeutics

AVTX

NASDAQHealth Care

Income Statement

Total Revenue$441K

Gross Profit$887K

Operating Income$0

EBITDA$0

EBIT$-46.1M

Pre-tax Income$-77.95M

Net Income$-62.31M

Balance Sheet

Cash Equivalent$125.05M

Total Debt$0

Book Value$133.03

Book Value Per Share12.70

Key Ratios

Return on Equity (ROE)-26.41%

Return on Assets (ROA)-23.31%

Return on Invested Capital (ROI)-26.41%

Net Profit Margin-7965.76%

Current Ratio19.96

Quick Ratio19.42

Long-Term Debt / Equity0.00